De novo variants in CUL3 are associated with global developmental delays with or without infantile spasms
- PMID: 32341456
- DOI: 10.1038/s10038-020-0758-2
De novo variants in CUL3 are associated with global developmental delays with or without infantile spasms
Abstract
The ubiquitin-proteasome system is the principal system for protein degradation mediated by ubiquitination and is involved in various cellular processes. Cullin-RING ligases (CRL) are one class of E3 ubiquitin ligases that mediate polyubiquitination of specific target proteins, leading to decomposition of the substrate. Cullin 3 (CUL3) is a member of the Cullin family proteins, which act as scaffolds of CRL. Here we describe three cases of global developmental delays, with or without epilepsy, who had de novo CUL3 variants. One missense variant c.854T>C, p.(Val285Ala) and two frameshift variants c.137delG, p.(Arg46Leufs*32) and c.1239del, p.(Asp413Glufs*42) were identified by whole-exome sequencing. The Val285 residue located in the Cullin N-terminal domain and p.Val285Ala CUL3 mutant showed significantly weaker interactions to the BTB domain proteins than wild-type CUL3. Our findings suggest that de novo CUL3 variants may cause structural instability of the CRL complex and impairment of the ubiquitin-proteasome system, leading to diverse neuropsychiatric disorders.
References
-
- Hershko A, Ciechanover A. Mechanisms of intracellular protein breakdown. Annu Rev Biochem. 1982;51:335–64. - PubMed
-
- Ciechanover A, Orian A, Schwartz AL. Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays. 2000;22:442–51. - PubMed
-
- Segref A, Hoppe T. Think locally: control of ubiquitin-dependent protein degradation in neurons. EMBO Rep. 2009;10:44–50. - PubMed
-
- Glickman MH, Ciechanover A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 2002;82:373–428. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- JP19ek0109280/Japan Agency for Medical Research and Development (AMED)
- JP19dm0107090/Japan Agency for Medical Research and Development (AMED)
- JP19ek0109301/Japan Agency for Medical Research and Development (AMED)
- JP19ek0109348/Japan Agency for Medical Research and Development (AMED)
- JP18kk020501/Japan Agency for Medical Research and Development (AMED)
LinkOut - more resources
Medical
Molecular Biology Databases